Fingerprint
Dive into the research topics of 'A phase I/II study of bortezomib in combination with paclitaxel, carboplatin, and concurrent thoracic radiation therapy for non-small-cell lung cancer: North Central Cancer Treatment Group (NCCTG)-N0321'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically